Compare CKX & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CKX | TRIB |
|---|---|---|
| Founded | 1930 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5M | 18.3M |
| IPO Year | 1998 | N/A |
| Metric | CKX | TRIB |
|---|---|---|
| Price | $9.26 | $0.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.2K | ★ 111.9K |
| Earning Date | 11-10-2025 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.14 | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | $897,333.00 | ★ $61,555,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | $41.11 | ★ N/A |
| Revenue Growth | N/A | ★ 8.31 |
| 52 Week Low | $8.66 | $0.48 |
| 52 Week High | $14.00 | $3.44 |
| Indicator | CKX | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 42.89 |
| Support Level | $9.15 | $0.88 |
| Resistance Level | $9.67 | $1.23 |
| Average True Range (ATR) | 0.44 | 0.11 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 33.52 | 8.43 |
CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.